Article Information
History
- August 1, 2018.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Junnian Wei1,#,
- Kevin K. Leung2,#,
- Charles Truillet3,
- Davide Ruggero4,5,
- James A. Wells2,5,* and
- Michael J. Evans1,2,5,*
- 1Department of Radiology and Biomedical Imaging, University of California San Francisco 505 Parnassus Ave, San Francisco CA 94143
- 2Department of Pharmaceutical Chemistry, University of California San Francisco, 505 Parnassus Ave, San Francisco CA 94143
- 3Imagerie Moleculaire In Vivo, INSERM, CEA, Univ. Paris Sud, CNRS, Universite Paris Saclay, CEA-Service Hospitalier Frederic Joliot, Orsay France, 94100
- 4Department of Urology, University of California San Francisco, 505 Parnassus Ave, San Francisco CA 94143
- 5Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, 505 Parnassus Ave, San Francisco CA 94143
- ↵*To whom the correspondence should be addressed: James A. Wells, jim.wells{at}ucsf.edu and Michael J. Evans, michael.evans{at}ucsf.edu
↵# These authors contributed equally.
Posted August 01, 2018.
Profiling the surface proteome identifies actionable biology for TSC1 mutant cells beyond mTORC1 signaling
